Leerink Partnrs Issues Pessimistic Outlook for NAMS Earnings
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Stock analysts at Leerink Partnrs reduced their FY2028 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research report issued on Thursday, February 27th. Leerink Partnrs analyst R. Ruiz now forecasts that the company will post earnings of $0.40 per share for the year, down […]
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Stock analysts at Leerink Partnrs reduced their FY2028 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research report issued on Thursday, February 27th. Leerink Partnrs analyst R. Ruiz now forecasts that the company will post earnings of $0.40 per share for the year, down […]
